Lilly(Eli) & Co (LLY) Stock Price, Graph, News & Analysis

Manufacturing (Pharmaceutical Preparation Manufacturing ) | NEW YORK STOCK EXCHANGE INC. : LLY

$298.85 $12.58 (4.39%)

Market Status : Closed
Last Update : 5/20/2022 4:04:08 PM

LLY

Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. It was founded more than a century ago by a man committed Read More

Historical Price Graph

Performance

1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year
7.58% 25.39% 15.62% 9.01% 51.62% 104.25% 329.99%

Details

Exchange
NEW YORK STOCK EXCHANGE INC.

Industry
Pharmaceutical Preparation Manufacturing

Website
www.lilly.com

Sector
Manufacturing

CEO
David Ricks

Total Employees
2,021

SIC Code
2834

Market Cap
$ 283.96 B

Key Statistics

Dividend Rate
$3.64

Last Dividend
2022-05-13

Dividend Yield
1.22%

P/E Ratio
44.41

Price Range (52 Week)
$192.78 - $312.95

Latest Volume
$ 2.46 M

Average Total Volume
$ 3.02 M

Outstanding Shares
950,159,559

Beta
60.77%

Similar Stocks

CompanySectorLatest PriceChange
BlackRock Institutional Trust Company N.A. - iShares Core S&P 500 ETF (IVV) Miscellaneous $391.30 $0.20
Bank Of America Corp. (BAC) Finance $33.86 -$0.59
Abbvie Inc (ABBV) Health Technology $151.01 -$0.71
Coca-Cola Co (KO) Consumer Non-Durables $60.98 $0.98
Vanguard Group, Inc. - Vanguard Total Stock Market ETF (VTI) Miscellaneous $195.32 $0.00

Lilly(Eli) & Co in News

STAT News (LLY,AZN-LN,AZN,ZEGA-GD,ZEGA-GB,ZEGA-GM,ZEGA-GS,ZEGA-GF,AZNCF,AZN-SS,FDA-IM)
STAT+: Pharmalittle: FDA rejects Lilly drug studied only in China; AstraZeneca suffers a setback with a key cancer drug The Food and Drug Administration declined to approve an Eli Lilly (LLY) lung cancer drug that had be
Mar 24, 2022 9:21 AM

Benzinga (LLY)
Insiders Sell About $138M Of 5 Stocks The Russian ruble declined against the US dollar on Monday after the Moscow Exchange resumed trading
Mar 21, 2022 8:32 AM

Seeking Alpha (LLY)
Lilly, Boehringer Ingelheim''s Jardiance gets EU approval for expanded use in heart failure The European Commission ((EC)) approved the expanded use of Eli Lilly (LLY) and Boehringer Ingelheim
Mar 8, 2022 5:42 AM

MarketWatch (LLY,RHHBY,INCY)
Preliminary U.K. research says Lilly drug can reduce the risk of death among severely ill COVID-19 patients A new study found that baricitinib, a rheumatoid arthritis drug developed by Eli Lilly & Co. and Inc
Mar 4, 2022 10:50 AM

Seeking Alpha (LLY,INCY)
Lilly/Incyte''s baricitinib reduces risk of death in COVID patients in UK study- Reuters A U.K. study showed that Eli Lilly (LLY) Incyte''s (INCY) Olumiant (baricitinib) helped reduce the r
Mar 4, 2022 4:48 AM

Dakota Financial News (LLY)
Eli Lilly and Company (NYSE:LLY) Shares Bought by Benjamin Edwards Inc. Benjamin Edwards Inc. raised its stake in Eli Lilly and Company (NYSE:LLY) by 20.0% during the third
Dec 24, 2021 10:04 AM

Seeking Alpha (LLY,LOW)
Stocks To Watch: Rivian Earnings, Samsara IPO And Events For Delta, Lowe''s And Eli Lilly No summary available.
Dec 11, 2021 9:53 AM

Transcript Daily (LLY,JPM)
Wells Fargo & Company Begins Coverage on Eli Lilly and (NYSE:LLY) Wells Fargo & Company initiated coverage on shares of Eli Lilly and (NYSE:LLY) in a research note pu
Dec 11, 2021 4:50 AM

OpenPR (JNJ,NVS,NOVN-SE,LLY,GSK-LN,GSK,ROG-SE,RHHBY,RO-SE,MRK,MRK-GY,MRK-GH,MRK-GD,MRK-GF,MRK-GM,MRK-GS,MRK-GI,MRK-GB,MKGAF,MKKGY,SNY,SAN-FP)
Medicine of Bioengineered Protein Market Notable Growth in CAGR +8% by end 2027|| GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Sanofi, Eli Lilly, Roche A Proteins play a crucial role in preserving both the physical and practical aspects of a specific c
Dec 7, 2021 3:02 AM

PR Newswire Asia (English) (INCY,LLY)
Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Dual Glucagon-like Peptide-1 and Glucagon Receptor Agonist in Chinese Patients with Type 2 Diabetes at the International Diabetes Federation Congress 2021 SAN FRANCISCO and SUZHOU, China , Dec. 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent")
Dec 6, 2021 7:00 PM

Common Questions Related to Lilly(Eli) & Co

When is Lilly(Eli) & Co next earning date?

Lilly(Eli) & Co next earning date is 2022-08-04

What is dividend yield of Lilly(Eli) & Co stock?

Lilly(Eli) & Co dividend yield is 0.012184124300923412 and Lilly(Eli) & Co announced last dividend in 2022-05-13 of amount $3.64/stock.

What is Lilly(Eli) & Co stock symbol?

Lilly(Eli) & Co traded in NEW YORK STOCK EXCHANGE INC. stock exchange and the stock symbol/ticker is LLY

What is the latest share price of Lilly(Eli) & Co (LLY)? or What is Lilly(Eli) & Co stock price today?

Lilly(Eli) & Co latest stock price is $298.85

Where is Lilly(Eli) & Co headquarter?

Lilly(Eli) & Co headquarter is at – Lilly Corporate Ctr, Indianapolis, Indiana, US

What is the total market cap of Lilly(Eli) & Co company?

The total market value of Lilly(Eli) & Co stock is $ 283.96 B

What is the P/E ratio of Lilly(Eli) & Co stock?

Lilly(Eli) & Co P/E ratio is 46.32750627431355

What is the EPS of Lilly(Eli) & Co stock?

Lilly(Eli) & Co EPS is 6.73

What is the Beta of Lilly(Eli) & Co stock?

Lilly(Eli) & Co Beta is 0.6077197412090299

Related Tags

Lilly(Eli) & Co stock price history, Lilly(Eli) & Co stock quote, LLY current stock price, Lilly(Eli) & Co dividend yield, Lilly(Eli) & Co Dividend, How much is Lilly(Eli) & Co worth